Editas Medicine




Katrine Bosley

Duke Inventor(s):

Charles Gerbach, Dave Ousterout, Pablo Perez-Pinera, Ami Kabadi

Building the leading genome editing company dedicated to treating patients with genetically defined diseases.

At Editas Medicine, we believe we have entered a new era in genomic medicine as the growth of genomic information in recent years has significantly expanded our understanding of genetically defined diseases. Furthermore, a new technology known as CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) has the potential to achieve accurate, directed changes in DNA and fulfill the promise that started with the sequencing of the human genome – the potential to treat diseases at their source, at the DNA level.